bluebird bio, Inc. financial data

Symbol
BLUE on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
Location
455 Grand Union Boulevard, Somerville, Massachusetts
State of incorporation
Delaware
Fiscal year end
December 31
Former names
Genetix Pharmaceuticals Inc (to 3/19/2010)
Latest financial report
Q3 2023 - Nov 7, 2023

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 202 % +25.4%
Quick Ratio 7.14 %
Debt-to-equity 138 % +11.8%
Return On Equity -34.3 % +81.5%
Return On Assets -14.4 % +82.7%
Operating Margin -8.72K % +69.9%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 109M shares +31.9%
Common Stock, Shares, Outstanding 107M shares +29.1%
Entity Public Float 302M USD -78.4%
Common Stock, Value, Issued 1.07M USD +29.2%
Weighted Average Number of Shares Outstanding, Basic 109M shares +33.8%
Weighted Average Number of Shares Outstanding, Diluted 109M shares +33.8%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 12.4M USD +17354%
Revenue from Contract with Customer, Excluding Assessed Tax 3.6M USD -1.78%
Cost of Revenue 11M USD
Research and Development Expense 180M USD -34.3%
Costs and Expenses 339M USD -23.5%
Operating Income (Loss) -136M USD +69.6%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -91.1M USD +78.9%
Income Tax Expense (Benefit) 30K USD -68.8%
Net Income (Loss) Attributable to Parent -91.2M USD +79.9%
Earnings Per Share, Basic -0.55 USD/shares +91%
Earnings Per Share, Diluted -2.21 USD/shares +50.2%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 165M USD +149%
Marketable Securities, Current 8.95M USD -87.8%
Inventory, Net 21M USD
Other Assets, Current 17.4M USD
Assets, Current 247M USD +54%
Property, Plant and Equipment, Net 9.97M USD -13.6%
Operating Lease, Right-of-Use Asset 295M USD +2.09%
Intangible Assets, Net (Excluding Goodwill) 5.37M USD
Goodwill 5.65M USD 0%
Other Assets, Noncurrent 50.8M USD -2.98%
Assets 614M USD +18%
Accounts Payable, Current 19.9M USD +6.61%
Employee-related Liabilities, Current 19.4M USD +1.46%
Contract with Customer, Liability, Current 9.65M USD +517%
Liabilities, Current 159M USD +25.4%
Operating Lease, Liability, Noncurrent 232M USD -1.02%
Other Liabilities, Noncurrent 92K USD 0%
Liabilities 391M USD +8.26%
Accumulated Other Comprehensive Income (Loss), Net of Tax -2.23M USD +51.9%
Retained Earnings (Accumulated Deficit) -4.11B USD -2.27%
Stockholders' Equity Attributable to Parent 223M USD +40.1%
Liabilities and Equity 614M USD +18%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -86.6M USD +30.9%
Net Cash Provided by (Used in) Financing Activities 130M USD +1449411%
Net Cash Provided by (Used in) Investing Activities 82.1M USD +17.5%
Common Stock, Shares Authorized 250M shares +100%
Common Stock, Shares, Issued 107M shares +29.1%
Common Stock, Par or Stated Value Per Share 0.01 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 126M USD
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 218M USD +95.7%
Deferred Tax Assets, Valuation Allowance 1.1B USD +7%
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent 0.21 pure 0%
Deferred Tax Assets, Gross 1.17B USD +11.5%
Operating Lease, Liability 281M USD +214%
Payments to Acquire Property, Plant, and Equipment 232K USD -72.9%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -88.8M USD +80.4%
Lessee, Operating Lease, Liability, to be Paid 352M USD +245%
Property, Plant and Equipment, Gross 27.1M USD -22.9%
Operating Lease, Liability, Current 71.7M USD +63.7%
Lessee, Operating Lease, Liability, to be Paid, Year Two 50.1M USD +133%
Lessee, Operating Lease, Liability, to be Paid, Year One 52.3M USD +93.5%
Operating Lease, Weighted Average Discount Rate, Percent 0.07 pure +39.8%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 71M USD +468%
Lessee, Operating Lease, Liability, to be Paid, Year Three 48.7M USD +171%
Deferred Tax Assets, Operating Loss Carryforwards 711M USD +1.1%
Preferred Stock, Shares Issued 0 shares
Deferred Federal Income Tax Expense (Benefit) 0 USD
Preferred Stock, Shares Authorized 5M shares 0%
Unrecognized Tax Benefits 23.7M USD +7.75%
Lessee, Operating Lease, Liability, to be Paid, Year Four 41.3M USD +182%
Operating Lease, Payments 51.4M USD +125%
Additional Paid in Capital 4.33B USD +3.64%
Preferred Stock, Shares Outstanding 0 shares
Current State and Local Tax Expense (Benefit) 0 USD
Current Federal Tax Expense (Benefit) 0 USD
Amortization of Intangible Assets 100K USD -75%
Depreciation, Depletion and Amortization 4.9M USD 0%
Share-based Payment Arrangement, Expense 20.7M USD -61.4%
Deferred State and Local Income Tax Expense (Benefit) 0 USD
Preferred Stock, Par or Stated Value Per Share 0.01 USD/shares 0%